Literature DB >> 26875011

Executive Functioning and School Performance among Pediatric Survivors of Complex Congenital Heart Disease.

Melissa Gerstle1, Dean W Beebe2, Dennis Drotar2, Amy Cassedy3, Bradley S Marino4.   

Abstract

OBJECTIVE: To investigate the presence and severity of real-world impairments in executive functioning-responsible for children's regulatory skills (metacognition, behavioral regulation)-and its potential impact on school performance among pediatric survivors of complex congenital heart disease (CHD). STUDY
DESIGN: Survivors of complex CHD aged 8-16 years (n = 143) and their parents/guardians from a regional CHD survivor registry participated (81% participation rate). Parents completed proxy measures of executive functioning, school competency, and school-related quality of life (QOL). Patients also completed a measure of school QOL and underwent IQ testing. Patients were categorized into 2 groups based on heart lesion complexity: 2-ventricle or single-ventricle.
RESULTS: Survivors of complex CHD performed significantly worse than norms for executive functioning, IQ, school competency, and school QOL. Metacognition was more severely affected than behavioral regulation, and metacognitive deficits were more often present in older children. Even after taking into account demographic factors, disease severity, and IQ, metacognition uniquely and strongly predicted poorer school performance. In exploratory analyses, patients with single-ventricle lesions were rated as having lower school competency and school QOL, and patients with 2-ventricle lesions were rated as having poorer behavioral regulation.
CONCLUSIONS: Survivors of complex CHD experience greater executive functioning difficulties than healthy peers, with metacognition particularly impacted and particularly relevant for day-to-day school performance. Especially in older children, clinicians should watch for metacognitive deficits, such as problems with organization, planning, self-monitoring, and follow-through on tasks.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac; child; cognitive; neuropsychology; scholastic

Mesh:

Year:  2016        PMID: 26875011      PMCID: PMC4884495          DOI: 10.1016/j.jpeds.2016.01.028

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

1.  Task force 1: the changing profile of congenital heart disease in adult life.

Authors:  C A Warnes; R Liberthson; G K Danielson; A Dore; L Harris; J I Hoffman; J Somerville; R G Williams; G D Webb
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

3.  National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001.

Authors:  Mark A Canfield; Margaret A Honein; Nataliya Yuskiv; Jian Xing; Cara T Mai; Julianne S Collins; Owen Devine; Joann Petrini; Tunu A Ramadhani; Charlotte A Hobbs; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

4.  Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome.

Authors:  W T Mahle; R R Clancy; E M Moss; M Gerdes; D R Jobes; G Wernovsky
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

5.  Quantitative magnetic resonance imaging of human brain development: ages 4-18.

Authors:  J N Giedd; J W Snell; N Lange; J C Rajapakse; B J Casey; P L Kozuch; A C Vaituzis; Y C Vauss; S D Hamburger; D Kaysen; J L Rapoport
Journal:  Cereb Cortex       Date:  1996 Jul-Aug       Impact factor: 5.357

6.  Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease.

Authors:  Adam R Cassidy; Matthew T White; David R DeMaso; Jane W Newburger; David C Bellinger
Journal:  J Int Neuropsychol Soc       Date:  2014-12-09       Impact factor: 2.892

7.  Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial.

Authors:  David C Bellinger; David Wypij; Adre J duPlessis; Leonard A Rappaport; Richard A Jonas; Gil Wernovsky; Jane W Newburger
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

8.  An MRI study of neurological injury before and after congenital heart surgery.

Authors:  William T Mahle; Federica Tavani; Robert A Zimmerman; Susan C Nicolson; Kristin K Galli; J William Gaynor; Robert R Clancy; Lisa M Montenegro; Thomas L Spray; Rosetta M Chiavacci; Gil Wernovsky; C Dean Kurth
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity.

Authors:  James W Varni; Tasha M Burwinkle; Michael Seid; Douglas Skarr
Journal:  Ambul Pediatr       Date:  2003 Nov-Dec

10.  Quality of life in adults with congenital heart disease.

Authors:  D A Lane; G Y H Lip; T A Millane
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

View more
  22 in total

1.  Preschool Neurodevelopmental Outcomes in Children with Congenital Heart Disease.

Authors:  Cheryl L Brosig; Laurel Bear; Sydney Allen; Raymond G Hoffmann; Amy Pan; Michele Frommelt; Kathleen A Mussatto
Journal:  J Pediatr       Date:  2017-01-09       Impact factor: 4.406

2.  Brain abnormalities in cognition, anxiety, and depression regulatory regions in adolescents with single ventricle heart disease.

Authors:  Nancy A Pike; Bhaswati Roy; Ritika Gupta; Sadhana Singh; Mary A Woo; Nancy J Halnon; Alan B Lewis; Rajesh Kumar
Journal:  J Neurosci Res       Date:  2018-01-06       Impact factor: 4.164

3.  Cerebellar development and its mediation role in cognitive planning in childhood.

Authors:  Judy A Kipping; Yingyao Xie; Anqi Qiu
Journal:  Hum Brain Mapp       Date:  2018-08-22       Impact factor: 5.038

4.  Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease.

Authors:  Cheryl L Brosig; Laurel Bear; Sydney Allen; Pippa Simpson; Liyun Zhang; Michele Frommelt; Kathleen A Mussatto
Journal:  Congenit Heart Dis       Date:  2018-09-06       Impact factor: 2.007

5.  Supporting Vulnerable Children after Life-Threatening Neonatal Illness: Opportunities for Improving Outcomes.

Authors:  Sarah A Sobotka; Michael E Msall
Journal:  J Pediatr       Date:  2016-08-15       Impact factor: 4.406

6.  Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition Project.

Authors:  Tracie C Rosser; Jamie O Edgin; George T Capone; Debra R Hamilton; Emily G Allen; Kenneth J Dooley; Payal Anand; John F Strang; A Chelsea Armour; Michelle A Frank-Crawford; Marie Moore Channell; Elizabeth I Pierpont; Eleanor Feingold; Cheryl L Maslen; Roger H Reeves; Stephanie L Sherman
Journal:  Am J Intellect Dev Disabil       Date:  2018-11

7.  Cognitive Function in Pediatric Hypoplastic Left Heart Syndrome: Systematic Review and Meta-Analysis.

Authors:  Rachel E Siciliano; Kemar V Prussien; Chelsea A Lee; Niral J Patel; Lexa K Murphy; Bruce E Compas; Lori C Jordan
Journal:  J Pediatr Psychol       Date:  2019-09-01

8.  Functional limitations and educational needs among children and adolescents with heart disease.

Authors:  Sherry L Farr; Karrie F Downing; Tiffany Riehle-Colarusso; Ginnie Abarbanell
Journal:  Congenit Heart Dis       Date:  2018-07-22       Impact factor: 2.007

9.  Quality of Life is Diminished in Patients with Tetralogy of Fallot with Mild Residual Disease: A Comparison of Tetralogy of Fallot and Isolated Valvar Pulmonary Stenosis.

Authors:  Shivani M Bhatt; Elizabeth Goldmuntz; Amy Cassedy; Bradley S Marino; Laura Mercer-Rosa
Journal:  Pediatr Cardiol       Date:  2017-08-31       Impact factor: 1.655

10.  Alterations in cerebral ventricle size in children with congenital heart disease.

Authors:  Laurie L Ackerman; Stephen F Kralik; Zachary Daniels; Anne Farrell; Marcus S Schamberger; Christopher W Mastropietro
Journal:  Childs Nerv Syst       Date:  2018-09-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.